Traduction de «Acheteur de produits pharmaceutiques » (Français → Anglais) :

It includes the name of the pharmaceutical product that is to be manufactured and sold for export under an authorization; the prescribed information in respect of the version of the product to be manufactured for export, which is there to pick up things such as the size, shape, and colour, as well as other distinguishing attributes; the maximum quantity of the product, which will be taken from the WTO website; the name of the patentee or patentees and the number of the patented invention as recorded in the Patent Office; the name of the importing jurisdiction; the name of the purchaser if it's not the importing jurisdiction itself; ...[+++] and any other information that may be prescribed, which is a safety valve in case something else is needed.

All Member States are increasingly making use of various cost-absorbing mechanisms such as patients’ own participation in hospital, medical or drug costs, special agreements on drugs (price maintenance, or the use of proprietary medicines) or contracts between the purchasers of health services and service providers (fixed annual budgets or diagnosis-related pricing groups for hospitals).

The development of electronic commerce has boosted the advertising and sale of pharmaceutical products on the Internet without a doctor's prescription, often endangering the lives of people who obtain the products (as in the case of a 24-year-old man in Britain).

The development of electronic commerce has boosted the advertising and sale of pharmaceutical products on the Internet without a doctor's prescription, often endangering the lives of people who obtain the products (as in the case of a 24-year-old man in Britain).

31. Considers that the single market in pharmaceuticals is incomplete and that the consequent market distortions are causing wide disparities in patient access to needed medicines; is therefore of the opinion that progressive liberalisation of the pharmaceutical market is needed in order to improve patient choice and access to high-quality, safe, efficacious and cost-effective medicines and to ensure that these medicines are available throughout the European Union; calls on the Commission to include in its programmes a proposal for a framework directive for completing the internal market in pharmaceuticals by introducing a gradual econ ...[+++]omic liberalisation of all sectors of the industry and to propose legislation to amend Directive 65/65/EEC on medicinal products with a view to harmonising and recasting regulatory data protection, in the light of the December 1998 European Court of Justice decision on generics;

Sanofi and Sterling Drug propose to combine their worldwide human prescription drug ("ethical") pharmaceutical activities (with the exclusion of Japan), and all their European human non-prescription (over- the-counter or "OTC") pharmaceutical activities.